Current Therapeutic Research
Title Abbreviation
Curr Ther Res Clin Exp
Electronic ISSN
1879-0313
Readership
Demographers, Epidemiologists, Health Scientists, Health Service Researchers, Outcomes Manager, Pain Specialists, Pharmacologists, Physicians, Public Health Professionals, Researchers
Scope
CTR is an open access, author-pays, online-only journal. Focuses on the rapid publication of peer-reviewed original reports of clinical trials and other developments in drug therapy, including papers presenting unexpected and/or negative results. Encourage the submission of research letters, presenting preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific drug therapies or disease states and applied health delivery or economics. CTR encourages and provides support for the submission of original reports from resource-limited settings: all studies of interventions designed to understand or improve disease treatment or disease prevention; public health policies that are "under-published" because of limited access to resources such as English language support, perceived lack of interest because of negative results, or because the study focused on problems that are uncommon in resource-rich countries; research in basic and clinical advances in pain; advancement of vaccines in developing countries; studies in pediatric respiratory and critical care treatment in underdeveloped countries.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Elsevier, Inc.
To see more details about Current Therapeutic Research,
Subscribe Now!
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines